Article Information
History
- September 7, 2022.
Article Versions
- Version 1 (April 12, 2022 - 22:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Peter J. Halfmann1,*,
- Nicholas R. Minor2,*,
- Luis A. Haddock III1,
- Robert Maddox2,
- Gage K. Moreno2,
- Katarina M. Braun1,
- David A. Baker2,
- Kasen K. Riemersa1,
- Ankur Prasad3,
- Kirsten J. Alman4,
- Matthew C. Lambert4,
- Kelsey Florek5,
- Allen Bateman5,
- Ryan Westergaard6,
- Nasia Safdar6,
- Dave R. Andes6,
- Yoshihiro Kawaoka1,
- Madiha Fida7,
- Joseph D. Yao8,
- Thomas C. Friedrich1 and
- David H. O’Connor2,^
- 1Department of Pathobiological Sciences, University of Wisconsin-Madison, Madison, WI, USA
- 2Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI, USA
- 3Department of Pulmonary and Critical Care Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA
- 4Division of Infectious Diseases, Department of Medicine, University of Wisconsin Hospitals and Clinics, Madison, WI, USA
- 5Wisconsin State Laboratory of Hygiene, Madison, WI, USA
- 6Department of Medicine, University of Wisconsin-Madison, Madison, WI, USA
- 7Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN, USA
- 8Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
- ↵^Address all correspondence to: dhoconno{at}wisc.edu
↵* These authors contributed equally to this manuscript
Posted September 07, 2022.
Evolution of a globally unique SARS-CoV-2 Spike E484T monoclonal antibody escape mutation in a persistently infected, immunocompromised individual
